<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Suggested benefit in PCV chemoradiotherapy for both IDH-mutant WHO-defined molecular subgroups	</title>
	<atom:link href="https://bioengineer.org/suggested-benefit-in-pcv-chemoradiotherapy-for-both-idh-mutant-who-defined-molecular-subgroups/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org/suggested-benefit-in-pcv-chemoradiotherapy-for-both-idh-mutant-who-defined-molecular-subgroups/</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 03 Jun 2019 11:44:32 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.4</generator>
</channel>
</rss>
